Qube Research & Technologies (QRT)
ALZN icon

Qube Research & Technologies (QRT)’s Alzamend Neuro ALZN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58
Closed -$97K – 2450
2022
Q1 		$97K Buy
+58
New +$109K ﹤0.01% 2076
2021
Q4 		– Sell
-38
Closed -$157K – 2492
2021
Q3 		$157K Buy
+38
New +$209K ﹤0.01% 1711

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCIA
Kingsbury Capital Investment Advisors Wilmette, Illinois $65.6M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALZN Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of Alzamend Neuro (ALZN) in Q2 2022, closing a stake of 58 shares — an estimated $97K sold.

Qube Research & Technologies (QRT) first reported a position in ALZN in Q3 2021 and held it in 2 quarters. The position peaked at $157K in Q3 2021. 20 funds tracked by Wall St. Rank hold ALZN as of Q2 2022.

  • Qube Research & Technologies (QRT) reported no remaining Alzamend Neuro position as of Q2 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 58 Alzamend Neuro shares in Q2 2022, an estimated $97K.
  • Qube Research & Technologies (QRT) first reported a position in Alzamend Neuro in Q3 2021 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Alzamend Neuro position peaked at $157K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.